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ABSTRACT 
 
Target Validation of a Myokinin Receptor from the Southern  
 
Cattle Tick Boophilus microplus (Canestrini).  (May 2006) 
 
Maria Adylia Blandon, B.S., Texas A&M University 
 
Chair of Advisory Committee: Dr. Patricia V. Pietrantonio 
 
 
A novel approach to control Boophilus microplus is to disrupt the physiological 
function of an endogenous myokinin receptor of this tick that was previously cloned in 
our laboratory.  To test the hypothesis that this myokinin receptor might be a suitable 
target for development of a novel acaricide, this target was validated by immunological 
disruption.  
A mixture of peptides, corresponding to the sequence of the extracellular loops of 
this receptor which were synthesized and linked to a carrier protein, was injected into 
Hereford cattle to induce an immunological response.  Immunological tests (ELISA) 
were developed to test the sera of these animals for antibody titers.  The data were 
analyzed using a randomized block split plot design and were compared between the 
control (calves numbers 407, 408, 427, 436, and 438) and peptide-injected calves (calves 
numbers 417, 420, 421, 426, and 435).  A gradual increase of antibody production was 
observed with the peptide-injected calves with bleed 4 showing the highest absorbances.   
Control calves and peptide-injected calves with high antibody titers were 
challenged with approximately 20,000 tick larvae at the USDA Cattle Tick Research 
laboratory.  The tick challenge test determined that disruption of the receptor function 
produces a detrimental effect on tick physiology (development, feeding and 
  
 
 iv
reproduction) by looking at percentage of molting, time of survivorship, number of ticks 
dropped, weight of fed females, weight of egg masses, and blood meal conversion.  The 
results, which were analyzed by a contingency table and a 2 sample T-test, did not 
support the hypothesis that the sera ingested from the peptide-injected cattle would cause 
a detrimental effect on tick physiology.  There was no statistical significance in the 
percentage of metanymphs molting from peptide-injected calves versus control calves (p 
= 0.282) and in the time of adult survivorship.  A statistical inference could be made 
about the number of ticks that dropped since four calves died of bovine babesiosis after 
the metanymphal collection.  There was no statistical significance in the weight of fed 
females (p = 0.061), weight of egg masses (p = 0.885), and bloodmeal conversion (p = 
0.312) from peptide-injected calves versus control calves. 
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CHAPTER I 
 
INTRODUCTION 
 
  
Overview 
 The Southern Cattle tick, Boophilus microplus (Canestrini), is a worldwide pest 
found in tropical and subtropical areas around the world (Nunez et al., 1985).  This 
species is a one- host tick, this means that it feeds and undergoes the larval, nymphal, 
and adult stages on one host, preferably cattle (Oliver, 1989).  Once the engorged adult 
female is ready to oviposit, she detaches from the host and lays one large egg mass, then 
death occurs.  Once the eggs hatch, the larvae start questing for a host.  The amount of 
time usually required to develop from unfed larvae to engorged adult female is 
approximately three weeks (Jongejan & Uilenberg, 2004).    
This tick is a primary vector of Babesia bigemina (Bock et al., 2004), a 
protozoan that is the causative agent of bovine babesiosis, also known as Texas Tick 
Fever.  Some of the main symptoms of Texas Tick Fever may include a high fever 
(>40ºC), urinating blood, anorexia, anemia, listlessness, and death (Bock et al., 2004).  
When a tick feeds on an infested animal, the Babesia parasites cross the midgut of the 
tick entering the hemolymph.  Three types of transmission can transmit this protozoan: 
(1) direct, tick to host through tick salivary glands; (2) transovarial, from mother to eggs, 
and (3) transtadial, one life stage to another. 
 
 
___________ 
This thesis follows the style and format of Insect Molecular Biology. 
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The southern cattle tick is a major economical pest, causing tremendous financial 
loss to cattle producers worldwide (Angus, 1996).  The prevalent areas of tick-related 
economic loss include Australia, Mexico, Central and South America, southern Africa, 
and parts of Asia (Baxter & Barker, 1999).  In Queensland, the cost of cattle tick 
infestation was about $141 million in 1999 (Jonsson et al., 2001).  This financial loss is 
also contributed by the cost of pesticides needed to prevent infestations and the decrease 
in milk and beef production caused by ticks when the pesticides are ineffective.  This 
tick also damages the hides of cattle, since they tend to feed where there is good leather 
potential (Jongejan & Uilenberg 2004).  This tick is also a major concern at the Mexico-
Texas border.  Since this tick is “endemic to Mexico” (Li et al., 2005) there is a threat of 
reintroduction of this pest to Texas.  In Texas, the estimated cost of physical losses and 
cost associated with controlling this species by means of mandatory dipping programs is 
$1,322,724,132 (Dietrich & Adams, 2000). 
 The method used to control Boophilus microplus employed by the United States 
Cattle Fever Tick Eradication Program is the application of chemical acaricides such as 
organophosphates, specifically coumaphos at a concentration of 0.3% (George, 2000) in 
dipping vats.  There are tick riders that inspect the cattle that enter Texas for ticks.  If 
ticks are found then the cattle will have to be dipped in the vats and quarantined for at 
least ten days.  If after ten days there are no ticks present then the cattle will be allowed 
into the U.S.  If there are ticks present, the cattle will be dipped a second time but will 
not be allowed in the U.S. (Davey et al., 2004).  
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Other methods of control include using other classes of acaricides, and breeding 
cattle that have naturally acquired resistance to tick infestations.  Other classes of 
acaricides that are commonly used in other places include carbamates, synthetic 
pyrethroids, amidine compounds, and acarine growth regulators.  These and 
experimental acaricides are routinely tested by means of various bioassays for efficacy.  
The acaricidal activity of benzimidazole-carbamate was compared in vitro and in vivo 
against permethrin and amitraz (White et al., 2005).  This benzimidazole-carbamate was 
more potent than permethrin in some species of ticks but less potent that permethrin in 
others.  The efficacy of eprinomectin, a pour-on that could be a possible alternative to 
dipping, was tested for control of Boophilus microplus (Aguirre et al., 2005).  The main 
effect of this acaricide was a reduction in the number of engorged females that dropped.  
Since most acaricides have oil adjuvants and are applied to cattle topically or in dipping 
vats, one problem that arises is the presence of residues in the milk and meat of the 
treated cattle (de la Fuente et al., 1998). 
 
Acaricide resistance 
The problem with using acaricides is that Boophilus microplus is known to 
develop resistance to these acaricides.  Resistance to two organophosphates, coumaphos 
and diazinon was reported in Mexican strains of Boophilus microplus (Li et al., 2003).  
The bioassay was the standardized Food and Agriculture Organization (FAO) larval 
packet test, consisting of Whatman filter paper permeated with different dilutions of 
pesticide to which larvae are exposed (Miller et al., 1999).  Probit analysis showed 
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significant cross-resistance between coumaphos and diazinon.  Amitraz resistance was 
also detected and characterized in this tick (Li et al., 2004).  Amitraz has been used in 
countries where high resistance to organophosphates and pyrethroids exist.  A FAO 
larval packet of different dilutions of amitraz was used to test resistance.  It was found 
that 11 out of the 15 Mexican strains tested showed a low-order resistance to amitraz (Li 
et al., 2004).  Recently resistance to carbaryl was diagnosed in the Mexican Strain of the 
Boophilus microplus (Li et al., 2005).  A FAO packet test with different dilutions of 
carbaryl was performed here as well.  It was concluded that there was more 
susceptibility to carbaryl than to coumaphos or diazinon in the tick strains from the 
quarantine zones from Texas.  The growing problem of resistance needs to be addressed 
by developing acaricides against novel targets in these ticks.   
 
Need for novel acaricide targets 
One target that merits validation is the myokinin receptor from Boophilus 
microplus.  Previous cloning, transcriptional expression, and functional analysis of this 
receptor was conducted by Steven P. Holmes at Texas A&M University in Dr. Patricia 
V. Pietrantonio’s laboratory (Holmes, 2003).  This receptor is a G protein-coupled 
receptor located on the plasma membrane of cells that is hypothesized to mediate the 
signal transduction cascade involved in myotropic and diuretic activity (Holmes et al., 
2000).  This myokinin receptor belongs to the Family A of G protein- coupled receptors 
known as the Rhodopsin/B2 adrenergic receptor-like family (Holmes et al., 2003).   
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G protein-coupled receptors have a predicted structure of seven transmembrane regions 
with the N-terminus and three loops outside the cell.  Inside the cell are the C-terminus 
and two loops.  Previous studies have provided evidence that the N-terminus and 
extracellular loops are involved in the binding of peptide ligands (Strader et al. 1994; 
Gudermann et al. 1995; Schwartz & Rosenkilde 1996).  When the ligand binds to the G 
protein-coupled receptor, the receptor undergoes a conformational change that activates 
a G protein.  The G protein α subunit dissociates from the βγ dimer and interacts with 
either adenylate cyclase or phopholipase C inducing a signal cascade such as production 
of cAMP or release of intercellular calcium stores, respectively (Sakmar et al., 2002).  
This system uses second messengers to amplify the signal transduced by the receptor 
upon ligand binding.     
The B. microplus receptor cloned is a leucokinin-like myokinin receptor.  The 
insect neuropeptide kinin and kinin analogs produced a functional response in the 
receptor (Holmes et al., 2003).  As of now, the endogenous ligand has not been 
identified in the ticks but research on kinins has been done in insects and other 
invertebrates (Torfs et al., 1999).  Attempts to identify the endogenous ligand resulted in 
the identification of a different neuropeptide, periviscerokinin (Neupert et al., 2005).  
The size of leucokinins is 6-15 amino acids in length, and were first discovered in 
Leucophaea maderae, a cockroach (Holman et al., 1986a,b).  The leucokinin’s function 
was to stimulate the hindgut contractions of the cockroach, and it was concluded that it 
has myotropic activity.  It has been tested electrophysiologically that the paracellular 
permeability to chloride in mosquito Malpighian tubules increased when leucokinins 
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were added (Wang et al., 1996).  Using a leucokinin photoaffinity analogue technique, a 
leucokinin-like binding protein in the Malpighian tubule of the Aedes aegypti mosquito 
was characterized (Pietrantonio et al., 2000) and the kinin receptor from mosquito was 
cloned, expressed and shown to respond to the three Aedes aegypti kinins (Pietrantonio 
et al., 2005).     
 
Tick physiology 
Water balance is an important physiological process involved in tick feeding, 
development, and reproduction (Sonenshine, 1991).  The main organs of osmoregulation 
in ticks are the salivary glands, excreting 70% of the water from a bloodmeal (Bowman 
& Sauer, 2004).  This water is eliminated through the salivary glands by “transformed 
“F” cells in the type III acini” (Sonenshine, 1991).  As the tick is feeding, the rate of 
fluid secretion of the salivary gland increases allowing the tick to concentrate the 
bloodmeal by returning excess water and ions to the host (Sauer et al., 1995).  The 
salivary glands are hypothesized to be controlled by the neurotransmitter dopamine 
(Kaufman, 1976).  Following the application of dopamine to isolated salivary glands 
from partially fed female adult ixodid ticks, fluid secretion of the salivary glands was 
induced (Kaufman, 1976). 
Osmoregulation across the gut wall supplies the excretory organs with excess 
water and ions (Agbede & Kemp, 1987).  Boophilus microplus ticks that dropped from 
cows after a bloodmeal were collected, dissected, and fixed for study under an electron 
microscope.  After dehydrating and re-hydrating the gut dissected fragments, there was 
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evidence to suggest it is the basophilic cells of the gut epithelium that draw water from 
the lumen and pass of into the hemolymph. 
The structure of the ovary has been morphologically and histologically studied 
by removing the ovaries, fixing, and staining them with bromophenol blue.  This 
confirmed the structure of the ovary as a “large U-shape” structure (Saito et al., 2005).  
Most of the bloodmeal of ixodid females is digested rapidly and is utilized for egg 
production (Oliver, 1989).  The oogenesis process in ticks begins during or immediately 
following the last nymphal feeding (Soneshine, 1991).  In Dr. Pietrantonio’s lab, the 
myokinin receptor transcript was found in the synganglion, salivary glands, ovaries, 
midgut, hindgut, and Malpighian tubules (Holmes et al., 2003) and this suggested the 
receptor could be a promising target to disrupt the function of various organs.    
 
Receptor target validation 
 Some of the main approaches used for target validation for pesticides and 
medicines are pharmalogical, genetic, and immunological.  The pharmalogical approach 
for target validation uses agonists and antagonists to produce either a normal response 
from the target when using agonists, or blocking the normal response when using the 
antagonist.  The genetic approach uses genetic mutations such as deletions or insertions 
to knockout the target gene (prevent transcription of mRNA) that is being validated, 
such as it is routinely done in Drosophila melanogaster.  This approach can also use 
RNA interference, which elicits the degradation of the messenger RNA, which in turns 
prevents translation of proteins (Blank & Bind, 2005).  
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The approach chosen to validate the tick myokinin receptor as a potential target 
for acaricide development was the immunological disruption of this receptor (Willadsen 
et al., 1989).  This approach elicits the host immune response and the production of 
antibodies against the receptor.  We chose receptor fragments that correspond to the 
predicted extracellular regions and partial transmembrane regions of the receptor as 
antigens.  It is expected that these antibodies when ingested by the tick will bind to the 
cell membrane-bound receptors and cause a disruption in the tick physiology (Willadsen 
& Kemp, 1988).  In the past, the strategy of inducing resistance of cattle to ticks has 
included vaccinating the cattle with tick antigens (Opdebeeck et al., 1988).  One such 
vaccine currently utilized is GAVAC™, (Heber Biotec S.A., Havana Cuba).  It is 
comprised of a recombinant Bm86 glycoprotein midgut antigen preparation (Redondo et 
al., 1999).  The myokinin receptor and the Bm 86 receptor are cell surface receptors, 
found embedded in the plasma membrane.  The extracellular regions of the receptor are 
in contact with the hemolymph while the intracellular regions are in contact with the 
cytoplasm.  After the tick has ingested the antibodies, the tick gut cells lyse (Gonzales et 
al., 2004).  The population of the tick decreases due in part to the reduction of fecundity 
that this vaccine induces (Rodriguez et al., 1995).  
 
Research objectives 
The goal of this research was to validate the B. microplus myokinin receptor as a 
novel target for acaricide development by means of immunological disruption.  The two 
specific objectives were to: (1) Induce an immunological response in the primary host of 
  
 
 9
this tick (Bos taurus, Hereford) to antigens corresponding to the extracellular loops and 
partial transmembrane regions of the myokinin receptor and; (2) Determine whether 
receptor disruption affects tick feeding, development, or reproduction by performing a 
tick challenge on immunized cattle. 
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CHAPTER II 
 
MYOKININ RECEPTOR ANTIGEN SYNTHESIS AND APPLICATION 
OF ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TO 
DETECT BOVINE ANTIBODIES AGAINST RECEPTOR FRAGMENTS 
 
 
Introduction 
 
This project aims at validating the myokinin receptor as a target for acaricides by 
disrupting the receptor’s normal function by immunological means.  One way to achieve 
validation is to interfere with the ligand binding site.  In this project, antibodies against 
the receptor will serve as the antagonists.  The hypothesis is that blocking of the binding 
site will prevent the normal physiological processes of the receptor to occur, thus 
causing detrimental damage to the tick.  This tick receptor is expected to produce an 
immunological response in cattle since this receptor is invertebrate-specific (Nässel, 
1996).  
Peptides corresponding to the receptor extracellular regions and to fragments of 
the transmembrane regions will be utilized as the antigen for antibody synthesis (Fig. 1).  
The antigen synthesis for antibody production in this experiment was modeled after the 
antigen synthesis and antibody production against the neuropeptide Y receptor, which is 
similar to the myokinin receptor (both in the Family A of G protein-coupled receptors) 
(Wieland et al., 1998).  In the aforementioned example there were 18 peptides designed 
corresponding to the extracellular loops of the Y-Y1 receptor which were conjugated 
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with bovine serum albumin (BSA) and injected into rabbits (Wieland et al., 1998), and 
an ELISA was performed to test the antibody titers. 
 
 
 
N-Terminus ECLoop 2 
 
 ECLoop 1 
 ECLoop 3 
C-Terminus 
Figure 1. A “snake diagram” of the Boophilus microplus myokinin receptor.  Adapted 
after Steven Holmes used Residue-based Diagram editor (RbDe), a web application 
found at http://icb.med.cornell.edu/services/rbde to create the predicated structure of the 
receptor.  There are seven transmembrane regions. The N-terminus and three 
extracellular loops are outside the membrane, while the C-terminus and two intracellular 
loops are inside the membrane.  EC codes for extracellular. 
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This chapter presents the hypothesis that myokinin receptor fragments are 
immunogenic in cattle.  For this, the antibody titers in calf serum will be estimated by 
ELISA.  The statistical analysis indicates that some, but not all of the receptor fragments 
are immunogenic in the calves. 
 
Methods 
 
 
Experimental animals 
 
Twelve Bos taurus castrated calves of 6-9 months in age were purchased by Dr. 
Chris Skaggs (Dept. of Animal Science, TAMU, Beef Center, manager) from Sutor 
Hereford Farms in Kansas, were transported to the Texas A&M Beef Center utilizing 
procedures discussed under AUP number 2003-0227, and maintained at this location 
from December 2004 to May 2005.  The calves were purchased in Kansas to obtain 
cattle that was naïve with respect to contact with B. microplus. 
 
Antigen synthesis 
A total of 13 peptides were designed that correspond to the extracellular regions 
of the cloned Boophilus microplus leucokinin-like peptide receptor (GeneBank/EMBL 
accession number AF228521) (Fig. 2, Table 1).  The peptides were 12- to 16- residues 
long with 3 residues overlapping (Wieland et al., 1998).  Some factors taken into 
consideration to design these peptides were the percentage of hydrophobic residues of 
the peptides (needed to be less than 50%), that the peptides themselves did not make 
secondary structures, and that there should be a least one charged residue for every five 
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amino acids (Collawn & Paterson, 1989).  A peptide calculator found on the Sigma 
Genosys webpage was utilized for those calculations.  A cysteine residue was added to 
the C-terminus of peptides 1-7, and 12, and to the N-terminus of peptides 9 and 11 to 
ensure linkage to Keyhole limpet hemocyanin (KLH).  KLH is a non-immunogenic 
carrier protein; a carrier protein is needed for the immune system of the calf to recognize 
these peptides, since these peptides are too small to be immunogenic without being 
presented by a carrier protein.   
 
N-Terminus ECLoop 2 
 
Figure 2.  A “snake diagram” of the Boophilus microplus myokinin receptor illustrating 
the 13 synthesized peptides corresponding to the extracellular regions.  The regions are 
shown as green lines and numbered respectively.  The ligand is hypothesized to bind to 
the extracellular regions.  
 
 
 
ECLoop 3 
ECLoop 1 
5 
6 
7 
11 
10 9 
8
12 13 
2
4 
 1 
3 
 
 
C- Terminus 
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Table 1.  Sequences of the 13 peptides designed that correspond to the  
extracellular regions and partial transmembrane regions of the tick myokinin 
receptor.  The underlined residues are the overlapping residues between two 
contiguous peptides.  The C in bold are the added cysteine residues needed for 
KLH conjugation. 
Name Peptide Number Sequence  
Location 
Sequence 
N-Terminus 1 Peptide 1 1-12 MTSLPGMTLDPSC 
N-Terminus 2 Peptide 2 10-21 DPSAPPPLLLDSC 
N-Terminus 3 Peptide 3 19-30 LDSSYVSPDYGNC 
N-Terminus 4 Peptide 4 28-39 YGNLSLLSSLPAC 
N-Terminus 5 Peptide 5 37-50 LPAANISSNKLYQVC 
Loop 1-1 Peptide 6 111-122 FQFQAALLQRWVC 
Loop 1-2 Peptide 7 118-129 LQRWVLPEFMCAC 
Loop 2-1 Peptide 8 188-199 CALALRVETQVE
Loop 2-2 Peptide 9 196-207 CTQVESHALNLTK
Loop 2-3 Peptide 10 205-216 LTKPFCHEVGIS
Loop 2-4 Peptide 11 214-225 CGISRKAWRIYNH 
Loop 3-1 Peptide 12 295-306 YNILREVFPKIDC 
Loop 3-2 Peptide 13 304-319 KIDKYKYINIIWFCTH 
 
 
 
 
  The peptides were purchased from Sigma Genosys (The Woodlands, TX) at 
95% purity.  A total amount of 5mg per peptide was purchased, of which 2 mg was 
conjugated with KLH, from Sigma Genosys (The Woodlands, TX).  Each conjugated 
peptide was reconstituted using 80% acetonitrile, 0.01% trifluoroacetic acid.  Peptides 
were aliquoted 500 µg in respective Eppendorf tubes.  Peptides were dried in a 
SpeedVac Plus (Savant SC110A) at low temperature (ambient) and stored at -80 ºC until 
use.  To coat the ELISA plates, 20ml of coating buffer was needed for one plate for each 
96 well to have 100 µl of buffer.  One 500 µg aliquot tube was resuspended with 80% 
acetonitrile, 0.01% trifluoroacetic acid and was re-aliquoted 20 µg in respective 
Eppendorf tubes and dried the same as before. 
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Immunization regime 
Immunizations for animals consisted in injecting a mixture of the 13 peptides, 
each conjugated to KLH for the treatment animals, and for control animals in injecting 
KLH only.  Once the peptides were synthesized, cattle injections were with the 
conjugated peptides or KLH only (controls) in adjuvant.  The first injection used Ribi’s 
adjuvant that induces a humoral immune response and has a minimal inflammatory 
response (Rudbach et al. 1988).  The subsequent injections used Freund’s Incomplete 
adjuvant.  The amount of peptide injected gradually increased so the calves’ immune 
system had time to adjust (Table 2).  
 The first immunization of the peptide-injected calves consisted of 100µg of 
KLH-conjugated peptide (8µg of each peptide and 8µg of carrier protein) mixed in 
Ribi’s adjuvant (Corixa Co., Seattle, WA)  injected into 6 calves.  The other 6 calves 
(controls) were injected with 100µg of KLH (Sigma; St. Louis, MI) only mixed in Ribi’s 
adjuvant.  The Ribi’s adjuvant was reconstituted with saline.  The immunizations were 
given intramuscularly in the neck using an 18-gauge, 1-inch hypodermic needle. 
The second immunization consisted of 100µg of KLH-conjugated peptide (8µg 
of each peptide) in saline mixed 1:1 with Freund’s Incomplete adjuvant (Sigma, St. 
Louis, MI) to treatment animals and 100 µg of KLH only to control animals.  The third 
immunizations consisted of 300µg of KLH-conjugated peptide (23µg of each peptide) in 
saline mixed 1:1 with Freund’s Incomplete adjuvant to treatment animals and 300µg of 
KLH only to control animals.  The fourth, fifth, and sixth immunizations consisted of 
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500µg of KLH-conjugated peptide (38µg of each peptide) in saline mixed 1:1 with 
Freund’s Incomplete adjuvant to treatment animals, and 500µg of KLH only to control 
animals.  The intervals between immunizations were 4 weeks for all calves (Table 2).  
One calf (Calf #415) did not receive immunizations four, five, and six due to unruly 
behavior. 
Before each immunization, the calves were bled by under the tail bleed technique 
and blood was collected in Vacutainer™ (BD, Franklin Lakes, NJ) tubes.  After 
coagulation of the blood at 4°C overnight, the serum was decanted into 15 ml conical 
tubes.  The serum was spun 15 min at 500 Xg (1500 rpm) in an IEC Centra CL2 table 
centrifuge, sodium azide was added to obtain a 15mMolar concentration in serum, and 
the serum was filtered manually using a .2µm syringe filter, and stored at -80 °C. 
 
 
Table 2.  Schedule of immunization regime.  The procedure, date  
of procedure, the amount of peptide (mixture of all 13 peptides only, not  
including KLH), and the location where the procedures took place is shown. 
Procedure Date Amount of 
Peptide 
Location 
Bleed 0 1/10/05  A&M Beef Center 
Injection 1 1/10/05 100 µg A&M Beef Center 
Bleed 1 2/17/05  A&M Beef Center 
Injection 2 2/17/05 300 µg A&M Beef Center 
Bleed 2 3/24/05  A&M Beef Center 
Injection 3 3/24/05 300 µg A&M Beef Center 
Bleed 3 4/28/05  A&M Beef Center 
Injection 4 4/28/05 500 µg A&M Beef Center 
Bleed 4 5/12/05  A&M Beef Center 
Injection 5 5/12/05 500 µg A&M Beef Center 
Injection 6 6/09/05  USDA Tick Lab 
Bleed 5 6/16/05 500 µg USDA Tick Lab 
Note: An equal amount of KLH is used to conjugate the peptides; thus 
the total amount of protein is double the number on the table. 
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Enzyme-linked immunosorbent assay (ELISA) 
 
Sera from the peptide-injected and control calves was tested for antibody 
production against the peptides using ELISA.  ELISAs were conducted using Costar 96-
Well Flat-Bottom EIA plates (Bio-Rad; Hercules, CA).  Controls for each step of the 
ELISA process were performed on every plate (Crowther, 2001).  The controls were as 
follows: one row with no conjugated peptide, one row with no serum, and one row with 
no secondary antibody (Fig. 3A).  Each plate was coated with 1µg of KLH conjugated 
peptide mixture/ml in a 50 mM carbonate coating buffer containing 15.01 mM Na2CO3, 
34.88 mM NaHCO3 pH 9.5 applying 100µl per well and incubating overnight at 4°C in a 
humid chamber.  The plates were washed twice with 1X phosphate buffer saline (PBS) 
containing 136.9 mM NaCl, 2.68 mM KCl, 1.01 mM Na2HPO4, 1.76 mM KH2PO4 pH 
7.4.  A blocking buffer of PBS with 5% rabbit serum (Jackson ImmunoResearch 
Laboratories, West Grove, PA) (200µl/well) was added to the plates and incubated at 
room temperature for 2 h.  Four dilutions of the serum in blocking buffer (1/50, 1/100, 
1/500, 1/1000) were added to the plate (200µl/well) and incubated overnight at 4°C in a 
humid chamber.  The plates were washed three times with PBS containing .05% Tween 
20 (PBST).  One hundred µl of rabbit anti-bovine IgG conjugated with alkaline 
phosphatase (Jackson ImmunoResearch Laboratories,West Grove, PA) diluted in 
1/10000 in blocking buffer were added to each well.  Incubation was at room 
temperature for 2 h.  The plates were washed three times with PBST.  One hundred µl of 
Alkaline Phosphatase Yellow (p-NPP) Liquid Substrate for ELISA (Sigma; St. Louis, 
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MI) was added to each well.  The optical density at 405 nm was measured with the 
ELISA VERSA Max plate reader from Molecular Probes (Eugene, OR) and the readings 
were for 30 min at 2 min intervals.  A positive result yielded a yellow color on the plate 
(Fig. 4). 
 
ELISA to detect calves titer toward individual peptides 
In order to determine if all peptides or only few of them were antigenic in cattle a 
different type of ELISA was conducted.  The ELISA plates were coated with 1 µg of 
each single KLH- linked peptide instead of 1 µg of the 13 KLH-linked peptide mixture 
to which KLH-linked peptide(s) were involved in the binding of the anti-receptor 
antibodies from the calves.  The control for the ELISA experiment was one column with 
no serum.  Only one dilution of serum (1:100) of each of the peptide-injected calves 
(#417, #420, #421, #426, and #435) from two bleeds (Bleed 4 and Bleed 0) was used for 
primary antibody binding step (Fig. 3B).  Bleed 4 was selected for this because it 
showed a higher antibody titer against the peptide mixture than Bleed 5. 
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         A) 
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No peptide     
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1:100 serum dilution     
1:500 serum dilution     
1:1000 serum dilution     
    
          B) 
 No serum  Peptide Bleed 0 Peptide Bleed 4  
Peptide 1    
Peptide 2    
Peptide 3    
Peptide 4    
Peptide 5    
Peptide 6    
Peptide 7    
Peptide 8    
 
Figure 3.  A schematic of an ELISA plate for testing antibody production. (A) A peptide 
mixture was used as coating antigen.  The no peptide, no serum, and no secondary 
antibody rows are the controls for the ELISA process.  The Bleed 0 and Control Bleeds 
are the negative controls for this project.  The serum dilutions for Bleeds 2 and 3 were 
1:10, 1:100, and 1:1000.  The serum dilutions for Bleeds 4 and 5 were 1:50, 1:100, 1:500 
and 1:1000.  Three replications of each plate for each of the bleeds were done.  (B) 
Single peptides were used as coating antigens and the serum from Bleed 4 and Bleed 0 
peptide-injected calves was the primary antibody.  Bleed 0 is control for specific binding 
for the peptides and no serum lane is the control for the ELISA process.  Peptides 9-13 
were coated on a separate plate because there are only 8 rows in the plates. 
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Figure 4.  An ELISA plate after the detection step.  A yellow color indicates a positive 
result. 
 
 
 
Data analyses 
Treatments were (1) control bleed 0; (2) control test bleed; (3) peptide-injected 
bleed 0, and (4) peptide-injected test bleed.  Data for these 4 treatment levels were 
arranged as a “randomized block split plot design” with plates as the blocking variable.  
The treated vs. control was the whole plot factor and the specific bleed number to be 
tested vs. control (bleed 0) was the split plot factor.  ANOVA procedure in the Statistical 
Package for the Social Sciences (SPSS) program was used to test the following 3 null 
hypothesis: (Ho 1) there was no statistical difference between control bleed 0 and control 
test bleed, (Ho 2) the absorbances of peptide-injected test bleed were equal to those of 
the peptide-injected bleed 0 and (Ho 3) the absorbances of peptide-injected test bleed 
were equal to those of the control test bleed.  The means and 95% confidence intervals 
for each treatment were compared for significant statistical differences.  For the analysis 
of the ELISA for single peptides the treatments were (1) peptide-injected bleed 0 and (2) 
peptide-injected bleed 4.  For the statistical analysis of the absorbances of ELISAs from 
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the peptide-injected Bleed 0 and Bleed 4 sera using the 13 individual KLH-bound 
peptides as coating antigens, ANOVA was used to testing the following 2 null 
hypothesis: (Ho 1) there was no statistical difference between peptide-injected bleed 0 
and peptide-injected bleed 4 and (Ho 2) there was no difference between the thirteen 
different peptides for bleed 4.  The means and the 95% confidence intervals for each 
treatment were compared for significant statistical differences.  For these tests the effect 
of individual animals has not taken into account as a source of variation so that this 
analysis answers which peptides across animals were more antigenic. 
 
Results 
To test the hypothesis that the calves were producing antibodies to these 
conjugated peptides, an indirect ELISA (Enzyme-Linked ImmunoSorbent Assay) test 
was conducted.  The theory of an indirect ELISA test is that when an antigen is bound to 
a plate a primary antibody will attach to the antigen, and a secondary antibody that is 
linked with an enzyme will bind to the primary antibody.  A substrate that will react to 
the enzyme will produce a response, such as a color change and that response will be 
measured.   
 Tables 3, 4, 5, and 6 show the mean value of absorbance and the 95% confidence 
intervals of the absorbances from the ELISAs from the control and peptide-injected 
calves.  There is no statistical evidence to indicate that the absorbances of the Control 
calves, Bleed 0 and the Peptide-injected Bleed 0 (pre-immune) calves differ.  In Bleed 2, 
we cannot reject the null hypotheses, that the absorbances of Bleed 2 are equal to Bleed 
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0, and that the absorbances of peptide-injected sera are equal to those of the control sera 
for all serum dilutions.  In Bleeds 3 and 4, we can reject the null the hypotheses that the 
absorbances of Bleeds 3 and 4 are equal to their respective Bleed 0, and that absorbances 
of sera from peptide-injected calves are equal to the control sera for all serum dilutions.  
Bleed 3 and Bleed 4 present statistical evidence that the absorbances of the peptide-
injected test bleeds are greater than the peptide-injected bleed 0.  For Bleed 5 we can 
only reject the null hypotheses that the absorbances of Bleed 5 are equal to Bleed 0, and 
absorbances of peptide-injected sera are equal to the control sera for sera dilutions 1:50 
and 1:100.  This evidence shows that the antibody production in the peptide-injected 
calves in the test bleeds (after several immunizations) was produced against the 
conjugated peptides that were injected and not due to an innate humoral response of the 
calf.    
The sera of Bleeds 2, 3, 4, of the peptide-injected cattle showed a gradual 
increase in antibody production with an increase of conjugated peptide injected.  For 
Bleed 2, 300µg of conjugated peptide was injected resulting in no statistical difference in 
the absorbances of the sera with respect to the control animals.  Similarly, 300µg of 
conjugated peptide was injected for Bleed 3, resulting in a statistical difference between 
the absorbances of the sera from peptide-injected cattle and the control calves.  For 
Bleed 4, 500µg of conjugated peptide was injected resulting in the highest absorbances 
of the peptide-injected test bleed.  The absorbances for the sera of the peptide-injected 
Bleed 5 cattle were higher than Bleed 3 but lower than Bleed 4.  This leads to the 
conclusion that the time of highest antibody production was four months (5/12/05) after 
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the initial injection of 100µg (1/10/05), and after 2 injections of 300µg (2/17/05 and 
3/24/05), and an injection of 500µg (4/28/05).  Figures 5, 6, 7, and 8 provide a graphic 
analysis of tables 3, 4, 5, and 6.   
 
 
 
Table 3.  Mean absorbances and 95% confidence intervals of Bleed 0 and  
Bleed 2 at three different dilutions.                                                                          
Treatment Mean  
Absorbance 
95% Confidence Interval 
of Absorbances 
1:10 dilution of serum   
Control Bleed 0 0.785 (0.628, 0.943)  
Control Bleed 2 0.813 (0.656, 0.970) ns 
Peptide-Injected Bleed 0 0.862 (0.717, 1.008)  
Peptide-Injected Bleed 2 1.148 (1.002, 1.293) ns 
1:100 dilution of serum   
Control Bleed 0 0.556 (0.434, 0.678)  
Control Bleed 2 0.660 (0.538, 0.783) ns 
Peptide-Injected Bleed 0 0.597 (0.484, 0.710)  
Peptide-Injected Bleed 2 0.844 (0.731, 0.958) ns 
1:1000 dilution of serum   
Control Bleed 0 0.409 (0.295, 0.523) 
Control Bleed 2 0.513 (0.399, 0.627) ns 
Peptide-Injected Bleed 0 0.413 (0.307, 0.519) 
Peptide-Injected Bleed 2 0.643 (0.537, 0.748) ns 
ns = Means are non significantly different from each other. 
There was no significant difference between the peptide-injected Bleed 0 and the 
peptide-injected Bleed 2 as there are no overlapping values of the confidence 
intervals. 
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Figure 5.  Histogram showing the average absorbance values at 405nm (Abs405) of 
Bleed 2 in comparison to Bleed 0 at several dilutions. (A)1:10 serum dilution (B)1:100 
serum dilution (C)1:1000 serum dilution.  Black vertical bars represent the 95% 
confidence intervals of Bleed 2 and Bleed 0. 
 
  
 
 25
       C) 
Bleed 2 and Bleed 0: 
1:1000 Serum Dilution
1.4
1.2
A
ve
ra
ge
  A
bs
40
5
1
0.8
0.6
0.4
0.2
0
Control B0 Control B2 Peptide B0 Peptide B2 
 
 
 
Figure 5. Continued. 
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Table 4.  Mean absorbances and 95% confidence intervals of Bleed 0 and  
  
ances 
95% Confidence Interval 
Bleed 3 at three different dilutions.   
Treatment Mean
Absorb of Absorbances 
1:10 dilution of serum   
Control Bleed 0 0.872 .687, 1.058)  (0
Control Bleed 3 0.821 (0.628, 1.013) ns 
Peptide-Injected Bleed 0 0.934 (0.763, 1.106)  
Peptide-Injected Bleed 3 1.625 (1.453, 1.797)** 
1:100 dilution of serum   
Control Bleed 0 0.557 .371, 0.743)  (0
Control Bleed 3 0.644 (0.452, 0.837) ns 
Peptide-Injected Bleed 0 0.602 (0.429, 0.774)  
Peptide-Injected Bleed 3 1.348 (1.176, 1.520)** 
1:1000 dilution of serum   
Control Bleed 0 0.376 .249, 0.503)  (0
Control Bleed 3 0.523 (0.392, 0.654) ns 
Peptide-Injected Bleed 0 0.387 (0.269, 0.504)  
Peptide-Injected Bleed 3 0.949 (0.832, 1.067)** 
   * ls were ant.  
ch other. 
injected Bleed 3 are 
                                      
 
     
* 95% Confidence Interva signific    
 ns = Means are non significantly different from ea
There is statistical evidence that the absorbances of peptide-
greater than peptide-injected Bleed 0 in all dilutions.  Control Bleed 0 and 
Control Bleed 3 were not statistically different in all dilutions.                     
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Figure 6.  Histogram showing the average absorbance values at 405nm (Abs405) of 
Bleed 3 in comparison to Bleed 0 at several dilutions. (A)1:10 serum dilution (B)1:1
serum dilution (C)1:1000 serum dilution.  Black vertical bars represent the 95% 
confidence intervals of Bleed 3 and Bleed 0. 
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Figure 6. Continued. 
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Table 5.  Mean absorbances and 95% confidence intervals of Bleed 0 and    
  
ances 
95% Confidence 
ances 
Bleed 4 at four different dilutions.   
Treatment Mean
Absorb Interval of Absorb
1:50 dilution of serum   
Control Bleed 0 0.898 .731, 1.065) (0
Control Bleed 4 1.040 (0.873, 1.207) ns 
Peptide-Injected Bleed 0 1.075 (0.925, 1.224) 
Peptide-Injected Bleed 4 1.684 (1.535, 1.833)** 
1:100 dilution of serum   
Control Bleed 0 0.730 .584, 0.877) (0
Control Bleed 4 0.966 (0.819, 1.112) ns 
Peptide-Injected Bleed 0 0.935 (0.805, 1.066) 
Peptide-Injected Bleed 4 1.490 (1.360, 1.621)** 
1:500 dilution of serum   
Control Bleed 0 0.517 .360, 0.674) (0
Control Bleed 4 0.806 (0.649, 0.963) ns 
Peptide-Injected Bleed 0 0.652 (0.511, 0.792) 
Peptide-Injected Bleed 4 1.235 (1.095, 1.376)** 
1:1000 dilution of serum   
Control Bleed 0 0.379 .210, 0.547) (0
Control Bleed 4 0.584 (0.416, 0.753) ns 
Peptide-Injected Bleed 0 0.503 (0.353, 0.654) 
Peptide-Injected Bleed 4 0.975 (0.824, 1.126)** 
** 95% Confidence Intervals were significant.     
 ch other. 
injected bleed 4 are 
 
      
 
ns = Means are non significantly different from ea
There is statistical evidence that the absorbances of peptide-
greater than those of peptide-injected bleed 0 in all dilutions.  Control Bleed 0 
and Control Bleed 4 were not statistically different for all dilutions. 
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Figure 7.  Histogram showing the average absorbance values at 405nm (Abs405) of 
Bleed 4 in comparison to Bleed 0 at several dilutions. (A)1:10 serum dilution (B)1:1
serum dilution (C)1:1000 serum dilution.  Black vertical bars represent the 95% 
confidence intervals of Bleed 4 and Bleed 0. 
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Figure 7. Continued. 
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Table 6.  Mean absorbances and 95% confidence intervals of Bleed 0 and  
fidence 
ances
Mean  
rbances 
Bleed 5 and four different dilutions.   
Treatment 95% Con
Interval of Absorb of Abso
1:50 dilution of serum   
Control Bleed 0 (0.745, 1.012) .878 0
Control Bleed 5 (0.638, 0.904) ns 0.771 
Peptide-Injected Bleed 0 (0.744, 1.011) 0.878 
Peptide-Injected Bleed 5 (1.213, 1.480)** 1.346 
1:100 dilution of serum   
Control Bleed 0 (0.589, 0.785) .687 0
Control Bleed 5 (0.516, 0.711) ns 0.614 
Peptide-Injected Bleed 0 (0.663, 0.859) 0.761 
Peptide-Injected Bleed 5 (1.031, 1.227)** 1.129 
1:500 dilution of serum   
Control Bleed 0 (0.475, 0.736) .606 0
Control Bleed 5 (0.375, 0.637) ns 0.506 
Peptide-Injected Bleed 0 (0.406, 0.668) 0.537 
Peptide-Injected Bleed 5 (0.687, 0.948)** 0.817 
1:1000 dilution of serum   
Control Bleed 0 (0.304, 0.536) .420 0
Control Bleed 5 (0.250, 0.482) ns 0.366 
Peptide-Injected Bleed 0 (0.263, 0.495) 0.420 
Peptide-Injected Bleed 5 (0.488, 0.720) ns 0.604 
** 95% Confidence Intervals were significant.     
 ch other. 
injected Bleed 5 are 
  
 
      
ns = Means are non significantly different from ea
There is statistical evidence that the absorbances of peptide-
greater than peptide-injected bleed 0 in dilutions 1:50, 1:100, and 1:500 dilutions.
Control Bleed 0 and Control Bleed 5 were not statistically different in all 
dilutions. 
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Figure 8.  Histogram showing the average absorbance values at 405nm (Abs405) of 
Bleed 5 in comparison to Bleed 0 at several dilutions. (A)1:10 serum dilution (B)1:1
serum dilution (C)1:1000 serum dilution.  Black vertical bars represent the 95% 
confidence intervals of Bleed 5 and Bleed 0. 
       
A
ve
ra
ge
  A
bs
40
5
Bleed 5 and Bleed 0: 
1.6
1:100 Serum Dilution
0 
0.2
0.4
0.6
1 
1.2
1.4
Control B0 Control B5 Peptide B0 Peptide B5 
.0.8
A
ve
ra
ge
  A
bs
40
5
Bleed 5 and Bleed 0: 
0
1.6
Control B0 Control B5 Peptide B0 Peptide B5 
1:50 Serum Dilution
1.2
1 
.8
0.6
0.4
0.2
0 
1.4
  
 
 34
       C) 
 
Figure 8. Continued. 
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Figure 9 shows the Abs405 of Bleed 4 at 1:50 dilution for all the peptide-injected 
calves.  The serum from Bleed 4 Calf #435 had the highest average absorption of 2.0.  
The serum from Bleed 4, Calf #412 had the lowest average absorption of 1.0.  The 
absorbance of the serum from Bleed 4, Calf #435 was double of that of Bleed 4, Calf# 
412.  The immune system of Calf #412 was not producing antibodies against the injected 
conjugated peptides.  This could suggest that the immune system of this calf was not as 
efficient as the other calves.  Calf #412 was not utilized in the tick challenge.  Only the 
calves in the tick challenge were bled for Bleed 5.   
 
 
 
Figure 9.  Histogram showing the average value of absorbances for peptide-injected 
calves sera Bleed 4.  The vertical black bars represent the 95% Confidence Intervals of 
the Abs405.  Calf #435 showed the highest mean value, followed by Calf #417, Calf 
#420, Calf #421, and Calf #426.  Calf #412 showed the lowest mean value. 
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 Table 7 and Figure 10 show the mean absorbance at 405 nm and the 95% 
Confidence Intervals of ELISAs from peptide-injected for Bleed 0 sera and Bleed 4 sera, 
1:100 dilution using the 13 individual KLH-bound peptides as coating antigen.  The null 
hypothesis is that the mean absorbances of Bleed 4 sera in ELISA using the individual 
13 peptides as coating antigen will be equal to the mean absorbance of Bleed 0 sera in 
that ELISA.  ELISA testing reveals antiserum reacted more strongly to wells containing 
peptides 2 and 9.  There is a statistical significance to show that the absorbances of the 
peptide-injected Bleed 4 towards Peptides 2, 3, 4, 5, 7, 8, 9, 11, 12 are greater than the 
absorbances of the peptide-injected Bleed 0 sera for the peptides 1-13.  The absorbances 
of peptide-injected Bleed 4 Peptides 2 and 9 are the highest of out of all 13 peptides with 
average absorbances of 1.549 and 1.746 respectively.  Peptides 2, 3, 4, 5 are found on 
the N-terminus, peptides 8, 9, and 11 are found on loop 2, and peptide 12 on loop 3.  
Peptide 2 corresponds to the N-terminus and Peptide 9 corresponds to loop 2 (Fig. 2).  
Peptides 1 corresponds to the N-terminus, Peptides 6 and 7 to loop 1, and Peptides 10 to 
loop 2, and Peptide 13 to loop 3 (Fig. 2).  Table 8 shows the individual mean 
absorbances of the ELISAs from each peptide-injected Bleed 4 calf using the 13 
individual KLH-bound peptides as coating antigen. 
When the 13 individual peptides were used as antigens, there was no statistical 
evidence that any of the peptides produced a differential absorbance when sera from 
Bleed 0 of treatment animals was tested in ELISA.  There was no statistical significance 
to show that the ELISA absorbances of the peptide-injected Bleed 4 when Peptides 1, 6, 
10, 13 were used as coating antigens are greater than the absorbances of the peptide-
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injected Bleed 0 sera for the peptides 1-13.  Peptide 1 is found on the N-terminus, 
peptides 6 and 7 are found on loop 1, peptide 10 is found on loop 2, and peptide 13 on 
loop 3.     
 
 
Table 7.  Mean absorbances and 95% confidence intervals of Abs405 of ELISAs 
from peptide-injected Bleed 0 and Bleed 4 sera using the 13 individual KLH-
bound peptides as coating antigens.  Sera dilution of 1:100 and was used.  
Peptides 2 and 9 showed the highest absorbances.  Peptides 1,6,7,10,13 showed 
the lowest absorbances.  
Peptide Mean of Absorbances 
 
95% Confidence Intervals of 
Absorbances 
 Bleed 0 Bleed 4 Bleed 0 Bleed 4 
Peptide 1 0.272 0.419 (0.153, 0.392) (0.300, 0.539) ns 
Peptide 2 0.363 1.549 (0.243, 0.482) (1.429, 1.668) ** 
Peptide 3 0.480 0.937 (0.361, 0.600) (0.817, 1.056) ** 
Peptide 4 0.461 0.836 (0.342, 0.581) (0.717, 0.956) ** 
Peptide 5 0.231 0.639 (0.112, 0.351) (0.519, 0.758) ** 
Peptide 6 0.234 0.442 (0.115, 0.354) (0.322, 0.561) ns 
Peptide 7 0.210 0.495 (0.090, 0.329) (0.375, 0.614) ** 
Peptide 8 0.305 1.095 (0.185, 0.424) (0.975, 1.214) ** 
Peptide 9 0.300 1.746 (0.181, 0.420) (1.627, 1.866) ** 
Peptide 10 0.232 0.417 (0.113, 0.352) (0.298, 0.536) ns 
Peptide 11 0.251 0.929 (0.131, 0.370) (0.809, 1.048) ** 
Peptide 12 0.282 0.897 (0.163, 0.420) (0.778, 1.017) ** 
Peptide 13 0.238 0.318 (0.119, 0.358) (0.198, 0.437) ns 
** 95% Confidence Intervals were significant.     
 ns = Means are non significantly different from each other. 
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Table 8. Individual mean absorbances of Abs405 of ELISAs from each peptide-
injected Bleed 4 calf using the 13 individual KLH-bound peptides as coating 
antigen.  Sera dilution of 1:100 was used. 
Peptide Calf 417 Calf 420 Calf 421 Calf 426 Calf 435 
1 0.314 0.489 0.505 0.375 0.412 
2 1.147 2.314 1.170 1.378 1.735 
3 0.511 0.970 0.883 0.716 0.903 
4 0.618 1.225 0.822 0.593 0.925 
5 0.409 0.957 0.664 0.453 0.711 
6 0.295 0.426 0.528 0.460 0.500 
7 0.281 0.883 0.469 0.381 0.461 
8 0.926 1.672 1.081 1.292 1.204 
9 1.925 2.397 1.522 1.373 1.514 
10 0.298 0.408 0.464 0.353 0.562 
11 0.644 1.322 0.972 0.796 0.909 
12 0.761 1.076 0.950 0.660 1.039 
13 0.255 0.336 0.360 0.304 0.333 
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Absorbencies of Individual  
Figure 10.  Histogram showing the mean absorbance in ELISA using the individual 
KLH-bound peptides as coating antigen.  The black vertical bars represent the 95% 
Confidence Intervals of Abs405 of peptide-injected Bleed 0 and Bleed 4, 1:100 sera 
dilution (Table 7).  The yellow stars represent a significant difference between Bleed 
4 and Bleed 0 for each peptide. 
 
 
Discussion 
 
The hypothesis that the cattle would produce an immunological response to the 
antigens corresponding to the extracellular regions of the Southern cattle tick myokinin 
receptor was supported by the results.  The absorbances of sera from Bleed 4 Peptide-
Injected calves as a group (calves #417, #420, #421, #426, and #435) were statistically 
different from Bleed 0 (the pre-immune) Peptide-Injected calves and Bleed 0, Bleed 4 
Control calves as a group ( calves #407, #408,#427,#436 and #438) indicating anti-
receptor antibody production in the Bleed 4 Peptide-Injected calves.  There was 
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differences within the calves with Calf #435 showing the highest absorbance in Bleed 4 
followed by Calf #417, Calf #420, Calf #421 and Calf #426 (Fig. 9).  Similarly, the 
extracellular region of plasma membrane receptors have been found to be immunogenic 
(Wieland et al. 1998).   
In previous studies, peptides have been utilized with success as antigens for 
antibody production in animals (Vordermeir et al., 2005).  A strong cellular immune 
response against bovine tuberculosis was induced by a synthetic peptide vaccine against 
it (Vordermeir et al., 2005).  The combination of the appropriate peptides and the 
suitable adjuvant formulation chosen enhances the immunogenicity of the peptides.  The 
results from the ELISA experiments support the hypothesis that peptides can be used as 
antigens given that the peptide-injected cattle did produce antibodies against the injected 
conjugated peptides.  The Bleed 4 Peptide-Injected sera bound to Peptides 2, 8, and 9 
showed the highest response (Fig. 10).  The absorbance rank order for the thirteen 
peptides was not similar in all five peptide-injected calves that were producing 
antibodies indicating variance between the calves (Table 8).     
The amino acid sequence of all 13 peptides was tested for hydrophobicity with 
the peptide calculator, found on the Sigma Genosys webpage, to detect a correlation 
between reduced hydrophobicity and immunogenicity.  The less hydrophobic the 
peptide, the higher the absorbance to the peptide-injected Bleed 4 sera.  For example, 
Peptide 2 (mean absorbance of 1.549) was 38.46% hydrophobic while Peptide 7 (mean 
absorbance of 0.495) was 53.33% hydrophobic.  However, “peptide immunogenicity 
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depends on complex interactions with various elements of the host immune system” 
(Van Regenmortel, 2001). 
The calves that did not produce antibodies were not going to be utilized for the 
tick challenge.  The absorbance of the sera from Calf #412 Bleed 4 was not statistically 
different from Calf #412 Bleed 0 (Pre-Immune) sera, reason for excluding that calf in the 
tick challenge.  The precaution of injections for a fifth time had to be taken to prevent a 
fall in antibody titer in serum from the time of the last injection in College Station 
(5/12/05) to the time of transfer of the calves to the USDA Cattle Fever Tick Laboratory 
(6/09/05).  The cattle were delayed when transferred to the Cattle Fever Tick laboratory 
so Injection 6 was given to ensure that the antibody was still being produced in the 
peptide-injected calves when they were challenged with Boophilus microplus ticks.  
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CHAPTER III 
Boophilus microplus CHALLENGE ON ANTI-MYOKININ 
RECEPTOR VACCINATED Bos taurus CALVES 
 
Introduction 
The tick challenge of receptor fragments-inoculated cattle is designed to test if 
the anti-myokinin receptor antibodies cause a detrimental effect on the tick.  This is 
determined by examining tick physiological functions such as feeding, development, and 
reproduction.  This receptor is hypothesized to be involved in diuresis and water balance 
(Holmes et al., 2000).  The myokinin receptor messenger RNA was detected in all life 
stages of the tick by semiquantitative RT-PCR (Holmes et al., 2000) so the tick 
challenge included testing for impairments in tick feeding, development, and 
reproduction.   
Evidence suggests that antibodies ingested by ticks are not digested but pass 
through the midgut barrier of the ticks (Tracey-Patte et al., 1987).  The host’s 
immunoglobin G (IgG) may disrupt essential biochemical functions leading to the tick’s 
death or inhibit its reproduction (Elvin & Kemp, 1994).  Anti-tick vaccines have shown 
a significantly reduced number of ticks engorging, reduction in weight after feeding, and 
reduction of conversion of engorged weight into eggs (Willadsen, 2004).  For example, 
the physiological response induced by the vaccine GAVAC is a reduction in the average 
fertility of the adult ticks (de la Fuente et al., 1998).  In the adult female soft tick 
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Ornithodoros moubata, mouse monoclonal antibodies against hemocytes given through 
an artificial membrane system had a tickcidal effect (Matsuo et al., 2004). 
A radioimmunoassay technique to measure the concentration of IgG in the 
hemolymph has been established and host IgG has been found in the tick hemolymph 
after ingestion of vaccinated blood (Ben-Yakir, 1989).  Immunoglobulins have been 
quantified by competitive ELISA in Boophilus microplus hemolymph (da Silva Vaz et 
al., 1996).  It was shown that 2%  of host IgG was present in the engorged tick 
hemolymph and is “present for at least 48 h after completing the parasitic life cycle” (da 
Silva Vaz et al., 1996).  Undigested host IgG has also been found in hemolymph during 
nymphal development of Dermacentor variabilis and Ixodes scapularis ticks (Vaughan 
et al., 2002).  The host IgG acquired by the fed larvae was detected by ELISA in the 
hemolymph of the non-fed nymphs that had molted from these larvae.   
 
Methods 
 
 
Tick challenge 
Five control and five peptide-injected calves were transported to the USDA Cattle 
Fever Tick Laboratory in Edinburg, TX.  The tick challenge consisted of a “natural” 
whole body infestation of larvae that could produce engorged females on each of the 
peptide-injected and control calves.  In addition, there was a confined subset of ticks on 
the flanks of each calf to possibly produce metanymphs to be detached to evaluate 
survivorship without a host, i.e., unfed adults.  The two calves not taken were Calf #415 
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(too unruly to be handled and could not be injected as per protocol) and Calf #412 (did 
not show an immune response against the receptor antigens).   
At the USDA laboratory, the calves were put into individual stanchions.  Each calf 
was infested with approximately 20,000 larvae produced from 1 gram of eggs 
(Drummond et al., 1973) of B. microplus of the Muñoz strain.  Two vials (each 500 mg 
of larvae) were glued to the middle of the back of the calves (Fig. 11).  Since 
metanymphs are ≤ 8mm in length (Nunez et al., 1985) and difficult to collect on the calf 
when they are free to move around, a patch was glued on one of the flanks of the all the 
calves.  Once the larvae were placed in this patch enclosure, it was stapled closed.   
 
 
 
Figure 11.  Tick challenge setup.  The calf in its stanchion with two vials containing 
500mg of larvae glued on its back.  The cotton plug in the vials in the picture was taken 
out of the vials to allow the larvae to attach to the hide of the calf. 
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Ixodid ticks rely upon active and passive water uptake mechanisms to maintain 
homeostasis (Sauer et al., 1995).  The insect growth regulator pyriproxyfen has been 
shown to negatively affect water balance in Amblyomma americanum, lonestar ticks and 
reduce their survival rate off the host (Strey et al., 2001).  Reduced survivorship of unfed 
adult lone star ticks emerging from pyriproxyfen-treated engorged nymphs held under 
constant conditions of temperature and relative humidity was a principle criteria to 
compare water homeostasis to untreated control ticks (Donahue et al., 1997).  
In the present study, water homeostasis of newly molted adult B. microplus was 
determined by comparative molting and survivorship of ticks from treated and control 
cattle.  When metanymphs were detected from the general body infestations, the patch 
was cut open with scissors.  Thirty metanymphs were manually detached with tweezers 
from the patches of each calf and put into vials (Fig.12).  The vials were incubated at 
28ºC and 92.5% humidity.  On a daily basis, the thirty metanymphs in the vials were 
inspected for molting into adults.  The adults that had molted from the metanymphs were 
inspected daily for mortality.   
 
 
 
 
 
 
 
  
 
 46
A)          B)          C)   
 
Figure 12.  Metanymph collection setup.  (A) The calf in its stanchion with a patch 
glued on.  The patch was cut open, the larvae placed inside, and the patch stapled closed.  
(B) After two weeks the patch was cut open to detach the metanymphs, seen here as dark 
dots.  (C) Thirty metanymphs from each calf were put into vials and incubated at 28ºC 
and 92.5% humidity. 
 
 
Adult engorged females that dropped from the calves were collected daily to test 
for any disruption in tick feeding.  After three weeks of infestation, the engorged females 
that dropped were collected by washing the stalls with water and letting the water flow 
into filters that caught the ticks.  The ticks were placed in disposable containers that 
were taken to the tick lab (Fig 13).  Then they were washed, counted, and weighed 
individually on previously tared filter paper.  A Metler electronic balance was used for 
weight measurements.  The weight for each individual engorged female tick (a sample 
size of thirty engorged females total collected over four days) that dropped from each 
calf (calves with the ear-tag numbers 408, 417, 426, 427, 436, and 438) and the date of 
the weight taken was recorded. 
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   A)              B) 
 
Figure 13.  Collection of engorged females setup. (A) The calf infested with Boophilus 
microplus.  (B) Once the engorged B. microplus females dropped from the calves they 
were collected, washed, and placed in plastic containers for counting.  
 
 
 
 
To test for any disruption in tick reproduction those thirty ticks from each calf 
were individually placed in vials, labeled with a number and the calf number they 
dropped from, and incubated at 28ºC and 92.5% humidity (Fig. 14).  Three weeks after 
they dropped, the date, the weight of the egg masses, and the weight of ticks after egg 
laying were recorded.  To inspect the ticks for any physical damage that incurred while 
blood feeding, the color of the tick after egg laying was recorded.  Engorged females are 
normally brown to reddish brown and any other coloration is considered abnormal. 
 
 
  
 
 48
 
Figure 14.  The female engorged ticks were collected in vials and incubated in a humid 
chamber that is maintained at 28ºC and 92.5% humidity. 
 
 
 
 
Data analyses 
 
Statistical significances between the number of ticks that molted from 
metanymphs into adults from the peptide-injected versus the control calves were 
evaluated by developing a 2x2 contingency table (Ott & Longnecker, 2001).  A 2 sample 
T-test was performed to test for statistical significance of the survivorship and the 
number of days to achieve 50% and 100% death of adult ticks that molted from the 
metanymphs from the peptide-injected calves versus the control calves.  The SPSS-PC 
program was used to perform the contingency table and the 2 sample T-tests.  A general 
statistical inference of the difference of ticks dropped from control calves versus the 
peptide-injected calves could not be made due to a limited sample size of calves.  After 
the ticks had molted on the calves but before the ticks had dropped, three peptide-
injected calves (Calf #420, Calf #421, Calf #435) and one control calf (Calf #407) died 
as result of bovine babesiosis.  In order to perform any statistical analysis of the 
measurements from the ticks from the remaining calves, the measurements from the 30 
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ticks per peptide-injected calf were pooled to compare with the pooled measurements of 
the ticks from control calves.  To test for a statistical significance in weight, egg mass 
weight, and bloodmeal conversion (the weight of the egg mass divided by the weight of 
the engorged female after she has dropped from the calf but before oviposition) between 
the ticks fallen from the peptide-injected calves versus the control calves a 2 sample T 
test was performed. 
 
Results 
 
Table 9 shows the comparison of the number of metanymphs that molted into 
adults after being detached from the peptide-injected and control calves, respectively.  
The null hypothesis that the number of metanymphs that molted into adult from peptide-
injected calves and from the control calves are equal, cannot be rejected (p = 0.282).  
That there is no difference between the percent survival of the adults from the peptide-
injected calves and the control calves is confirmed in Figure 15 showing the percent 
survivorship of the newly molted adults from the metanymphs that had been detached.  
In order to confirm that indeed there was no difference in the survivorship of the 2 
groups, the number of days to achieve 50% and 100% death was compared between 
groups, tables 10 and 11 show those comparisons.  The null hypotheses that the date of 
50% cumulative death occurrence and 100% cumulative death occurrence of the peptide-
injected calves are similar from the control calves cannot be rejected (p = 0.865 and p = 
0.291 respectively).  
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Table 9.  Comparison of the number of metanymphs that molted into adult from 
the peptide-injected calves and the control calves.  A 2x2 contingency table is 
shown.  There is no statistical difference in the number of ticks molted from the 
peptide-injected calves versus the control calves (p = 0.282). 
 Peptide-Injected Control 
Number of ticks molted 128 121 
Number of ticks not 
molted 
22 29 
Total 150 150 
n=300, d.f.=1, χ² = 1.158, p = 0.282 
 
 
 
Survivorship of Newly Molted Adults
0
0.2
0.4
0.6
0.8
1
1.2
6/3
0/2
00
5
7/2
/20
05
7/4
/20
05
7/6
/20
05
7/8
/20
05
7/1
0/2
00
5
7/1
2/2
00
5
7/1
4/2
00
5
7/1
6/2
00
5
Peptide-
injected
Control
 
%
 A
liv
e 
ou
t o
f M
ol
te
d 
Figure 15.  The survivorship of newly molted adults.  The percentage alive for each day 
for ticks obtained from control calves and peptide injected calves is graphed.  The lines 
are parallel; there is no difference in the percentage alive from the newly molted adults 
detached from the peptide-injected calves versus control calves.    
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Table 10.  Comparison of date of 50% cumulative death occurrence of ticks 
collected from control and peptide-injected calves.  There is no statistical 
difference between the date of 50% cumulative death occurrence of newly 
molted adults collected from peptide-injected calves versus control calves (p = 
0.865). 
Calf Date of 50% 
cumulative death 
Days from initial 
detachment (6/30/05) 
Control:   
Calf #407 7/11/05 12 
Calf #408 7/11/05 12 
Calf #427 7/07/05 8 
Calf #436 7/11/05 12 
Calf #438 7/08/05 9 
Peptide-Injected:   
Calf #417 7/11/05 12 
Calf #420 7/11/05 12 
Calf #421 7/08/05 9 
Calf #426 7/11/05 12 
Calf #435 7/08/05 9 
n=10, d.f.= 8, t= -0.175, p= 0.865 
 
 
Table 11.  Comparison of date of 100% cumulative death occurrence of ticks 
collected from control calves and peptide-injected calves.  There is no statistical 
difference between the date of 100% cumulative death occurrence of newly 
molted adults picked from the peptide-injected calves versus control calves (p = 
0.291). 
Calf Date of 100% 
cumulative death 
Days from initial  
detachment (6/30/05) 
Control:   
Calf #407 7/15/05 16 
Calf #408 7/16/05 17 
Calf #427 7/13/05 14 
Calf #436 7/14/05 15 
Calf #438 7/16/05 17 
Peptide-Injected:   
Calf #417 7/16/05 17 
Calf #420 7/16/05 17 
Calf #421 7/14/05 15 
Calf #426 7/16/05 17 
Calf #435 7/16/05 17 
n=10, d.f.= 8, t= -1.131, p= 0.291 
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Table 12 and Figure 16 show the frequency distribution of ticks that dropped 
daily from peptide-injected calves 417 and 426, and from control calves 408, 426, 436, 
and 438.  No statistical inference can be made from the data due to the low numbers of 
calves.  Four calves (control Calf #417, and peptide-injected calves #420, #421, and 
#435) died from bovine babesiosis.  The distributions of the ticks that dropped from all 
the calves (except Calf #427) appear skewed to the left.  Calf #427 dropped late in the 
drop, with a long period of dropping but a small number of drops continuously.   
Figures 17, 18, and 19 show the pooled data of the average weight of engorged 
female ticks, the average weight of the their egg masses and the conversion of bloodmeal 
that dropped from peptide-injected calves (60 ticks) and control calves (120 ticks), as 
well as the individual averages for each calf.  The null hypothesis that the average 
weight of fed females from peptide-injected calves is similar from those of the control 
calves cannot be rejected (p = 0.061).  The null hypothesis that the average weight of 
their egg masses from peptide-injected calves is similar than that of the control calves 
cannot be rejected (p = 0.885).  The null hypothesis that the conversion of the bloodmeal 
from peptide-injected calves is similar from that of the control calves cannot be rejected 
(p = 0.312). 
 
 
 
 
 
 
 
 
 
  
 
 53
Table 12.  Tick challenge experiment: frequency distribution of ticks that 
dropped from calves on a daily basis.  Calves 408, 427, 436, and 438 are control 
calves.  Calves 417 and 426 are peptide-injected calves.  The first drop was on 
7/8/05 from Calf #408 and Calf #438.  The last drop was on 8/02/05 from Calf 
#427.  With the exception of the ticks from Calf #427, there was a short time of 
dropping with a large number of drops in the middle of the drop time.  The ticks 
from Calf #427 dropped with small numbers over a longer period of time.  Not 
an expected result from a control calf. 
 CONTROL CALVES PEPTIDE INJECTED 
CALVES 
Date  #408  #427  #436 #438  #417  #426 
7/08/05 8 0 0 5 0 0 
7/09/05 158 0 0 52 0 3 
7/10/05 398 0 19 256 0 22 
7/11/05 809 0 196 588 1 146 
7/12/05 491 1 351 763 20 350 
7/13/05 394 1 576 668 76 496 
7/14/05 270 3 484 379 155 390 
7/15/05 101 12 170 83 364 443 
7/16/05 50 13 210 107 224 247 
7/17/05 19 33 104 97 285 262 
7/18/05 6 45 69 81 268 129 
7/19/05 3 76 27 15 232 99 
7/21/05 3 80 40 19 99 31 
7/22/05 0 101 10 10 92 29 
7/23/05 0 74 6 1 25 16 
7/24/05 0 52 2 3 21 4 
7/25/05 0 76 2 0 7 6 
7/26/05 0 47 0 0 12 3 
7/27/05 0 54 0 0 5 2 
7/28/05 0 33 0 2 3 0 
7/29/05 0 20 0 0 2 0 
7/30/05 0 15 0 0 1 0 
7/31/05 0 15 0 0 0 0 
8/01/05 0 13 0 0 0 0 
8/02/05 0 3 0 0 0 0 
Total  2710 767 2266 3129 1892 2678 
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Frequency Distribution of Ticks Dropped 
 
Figure 16.  Frequency distribution of the ticks dropped from the tick challenge 
experiment (Table 11).  Bars represent the number of ticks that dropped daily.  The 
control calves are #408, #427, #436, #438 and the peptide-injected calves #417 and 
#426. 
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Figure 17.  Comparison of the average weight of engorged Boophilus microplus 
(Canestrini) females dropped from control calves and peptide injected calves. (A) The 
weights of ticks from control cattle and peptide-injected cattle were pooled among 
calves in these two treatments for statistical analysis.  There is no statistical difference in 
the average weight of fed ticks dropped from the peptide-injected calves versus the 
control calves (p = 0.061). (B) Descriptive statistics of average weight of ticks for each 
individual calf. 
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Figure 18.  Comparison of the average weight of the egg masses oviposited by the 
Boophilus microplus (Canestrini) females that dropped from control calves and peptide 
injected calves.  (A) The weights of the egg masses from ticks that dropped from control 
cattle and peptide-injected cattle were pooled among calves in these two treatments for 
statistical analysis.  There is no statistical difference in the average weight of fed ticks 
dropped from the peptide-injected calves versus the control calves (p = 0.885). (B) 
Descriptive statistics of average weight of the egg masses of the ticks for each individual 
calf. 
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(B)  
 
Figure 19.  Comparison of the average bloodmeal conversion (weight of egg mass 
divided by the weight of the engorged female after she has dropped but before 
oviposition) of the Boophilus microplus (Canestrini) females that dropped from control 
calves and peptide injected calves. (A) The bloodmeal conversion from ticks that 
dropped from control cattle and peptide-injected cattle were pooled among calves in 
these two treatments for statistical analysis.  There is no statistical difference in the 
average bloodmeal conversion of the ticks dropped from the peptide-injected calves 
versus the control calves (p = 0.312). (B) Descriptive statistics of average bloodmeal 
conversion of ticks for each individual calf.  
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Discussion 
 
The objective was to validate the myokinin receptor by immunological means as 
a suitable target for development of novel acaricides.  In previous studies, immunization 
of cattle with Tick-GARD (Bm86 vaccine) resulted in reduction in number of larvae and 
adult ticks found on the host (Pipano et al., 2003).  The results of this research do not 
concur.  The hypothesis that antibodies presented in cattle against the myokinin receptor 
would disrupt tick physiology in development of the Boophilus microplus tick was not 
supported by the results of these experiments.  There was no statistical difference in the 
number of metanymphs that molted into adults detached from the peptide-injected calves 
versus those from control calves.  The numbers were almost the same for both 
treatments.  There was no statistical significant difference between groups in 
survivorship, the time to achieve 50% death, and the time to achieve 100% death of the 
newly molted adults from the peptide-injected calves versus those from the control 
calves.  The lines for the survivorship (Fig. 15) were parallel for both treatments.  The 
results were not what was expected since in a previous study, Amblyomma americanum 
adults that molted from larvae and nymphs that were in glass vials treated with the 
acaricide pyriproxyfen were lethargic and short-lived compared with adults that molted 
from larvae and nymphs in untreated glass vials (Donahue et al., 1997).  
From 07/03/05 to 07/05/05, four calves (Control Calf #407 and Peptide-injected 
Calves #420, #421, and #435) died due to bovine babesiosis.  Investigations into the 
cause of the disease suggested that the laboratory Muñoz colony was the source of 
Babesia bigemina since four animals died almost simultaneously, suggesting a 
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simultaneous infection.  It is possible that the immune systems of the peptide-injected 
calves were more compromised than those of the control calves to overcome the 
protozoan infection because the three peptide-injected calves that died were producing 
high levels of the antibody (shown by high absorbances in the ELISA experiments).   
The hypothesis that the myokinin receptor disruption affects feeding of the B. 
microplus tick was not supported by these results.  The data collected on the number of 
engorged female B. microplus ticks that dropped was limited to 4 control calves and 2 
peptide-injected calves.  The number of ticks that dropped from each calf was collected 
but no statistical analyses of this drop could be performed because there were only 2 
peptide-injected calves left, therefore a reliable estimate of variance cannot be computed.  
However, one observation can be made from Table 11 and figure 16.  The ticks from 
control Calf #427 did not drop as uniformly as those from the other five calves.  The 
time to drop was delayed but extended with respect to that of the other five calves, and 
the number of ticks that dropped each day were less than any of the ones dropped from 
the other five calves.  One reason in this could be that the ticks did not prefer Calf #427 
as a host.  For the statistical analysis, the weights of the ticks dropped from the peptide-
injected calves were pooled (30 weights from two calves for a total of 60 weights) and 
compared to the pooled weights of the ticks dropped from the control calves (30 weights 
from four calves for a total of 120 weights).  There is no statistical significant difference 
in the average weight of the females from the control calves versus the peptide-injected 
calves.  There was also no color change to indicate physiological distress in any ticks 
that dropped. 
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The hypothesis that the myokinin receptor disruption affects reproduction of the 
B. microplus tick was not supported by these results.  There is no statistical significant 
difference in the average weight of the egg mass and the average bloodmeal conversion 
of the pooled data from the control calves versus the peptide-injected calves.   
One reason for the absence of any effect to the physiological processes of the 
ticks could be that the calf antibodies are not binding to the myokinin receptor of the cell 
membrane of the ticks.  The myokinin receptor in the cell membrane could have a 
tertiary structure different from that of the injected peptides.  One way to test for 
antibody binding is through western blot or histochemistry.  Membranes containing the 
myokinin receptor can be isolated and tested by western blots with sera from the 5 
calves.  If a band that is of the expected size of the myokinin receptor is detected in the 
western blot, then the antibody was binding to the myokinin receptor.  If the antibody 
does bind to the receptor, then an alternative reason for the null effect of the tick 
challenge could be not enough concentration of the antibody in the bloodmeal. 
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CHAPTER IV 
CONCLUSION 
 
This thesis demonstrated that peptides designed to correspond to the N-terminus 
(Peptides 2, 3, 4, and 5), extracellular loops (Peptides 7, 8, 9, 11, and 12), and part of the 
transmembrane regions of the myokinin receptor from the Boophilus microplus tick are 
antigenic in cattle.  There was no statistical evidence to suggest that there was a 
physiological detrimental effect on ticks that fed on immunogenic cattle.  The death of 
four calves from babesiosis impeded part of the tick challenge experiment.  Further 
investigation is needed for target validation of this myokinin receptor.  
A mixture of 13 peptides (12-16 amino acids in length) linked to KLH (Keyhole 
limpet hemocyanin) was injected into six calves following a defined immunization 
regime.  Six control calves, following the same immunization regime, received KLH 
only injections.  An indirect ELISA (Enzyme-Linked ImmunoSorbent Assay) was 
developed to determine antibody titers on the sera of these calves.  There was statistical 
evidence to indicate that sera from Peptide-injected Bleed 4 calves have the highest 
absorbance out of five bleeds.  Generally, absorbances increased with successive bleeds, 
but the absorbance decreased by a small amount for Bleed 5.  The absorbance of sera 
from Calf #412 Bleed 4 was not significantly different from Calf #412 Bleed 0, thus this 
calf was not used for the tick challenge.  The sera from Calves #417, #420, #421, #426, 
and #435 Bleed 4 showed the highest absorbance when bound to Peptides 2, 8, and 9, 
and the lowest absorbance when bound to Peptides 1, 6, 7, 10, 13.  
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Peptide-injected calves (#417, #420, #421, #426, and #435) and control calves 
(#407, #408, #427, #436, and #438) were transported to the USDA Cattle Fever Tick 
Laboratory in Edinburg, TX for the tick challenge experiments.  Approximately 20,000 
larvae were infested on each calf to test the anti-myokinin receptor antibodies for any 
detrimental effects on tick physiology to validate this receptor as a novel target for 
acaricides.  There was no statistical evidence that the percentage of survival and the time 
to achieve cumulative 50% and 100% death of adults molted from the metanymphs 
collected from the peptide-injected calves was different from those from the control 
calves.   
A week after the metanymphs were collected, four calves (peptide-injected 
calves #420, #421, #435, and control calf #407) died due to bovine babesiosis.  The 
female engorged ticks that dropped from the remaining surviving calves (peptide-
injected calves #417, #435, and control calves #408, #427, #436, and #438) were 
collected to measure their weight, the weight of their egg masses and their bloodmeal 
conversion.  For statistical analysis, the weights of the engorged females, egg masses, 
and bloodmeal conversions from all the peptide-injected calves were pooled to compare 
with all the pooled data of the control calves.  There was no statistical evidence to 
indicate that there was a difference in the average of weights of the ticks, the average 
weights of their egg masses and the average bloodmeal conversions of ticks that dropped 
from the peptide-injected calves versus those that dropped from the control calves. 
The sera of Peptide-injected calves (except Calf #412) are a resource for future 
studies to validate the myokinin receptor as an acaricidal target.  Future studies include 
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injecting the sera directly into the engorged female to test for any difference in weight of 
the egg masses.  The sera can be used in western blots, immunocytochemisty and in-vivo 
cell assays for direct visualization of antibody-receptor binding in the first two and for 
blocking of the myokinin-induced intracellular calcium response in the later. 
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APPENDIX I  
 
 Example of SPSS output for analyzing ELISA data. 
I) Test to determine if the peptide-injected calves were producing antibodies.  This is an 
example of Bleed 4 and Bleed 0, 1:50 dilution data output.  Refer to Chapter II Table 6 
and Figure 7a. 
 
A) 
Between-Subjects Factors 
 
  Value Label N 
1.00 Peptide-
Injected 36
TRT 
2.00 Control 30
1.00 Bleed 0 33BLEED 
2.00 Bleed 4 33
1.00 Plate 1 12
2.00 Plate 2 10
3.00 Plate 3 12
4.00 Plate 4 10
5.00 Plate 5 12
PLATE 
6.00 Plate 6 10
Note: N stands for the number of wells in the plate for three ELISA experiment 
repetitions corresponding to the categories of the value label.  
 
B) 
Tests of Between-Subjects Effects 
 
Dependent Variable: ABS  
Source 
Type III Sum 
of Squares Df Mean Square F Sig. 
Hypothesis 88.228 1 88.228 51.893 .001Intercept 
Error 8.511 5.006 1.700(a)    
Hypothesis 8.581 5 1.716 16.665 .004PLATE 
Error .515 5 .103(b)    
Hypothesis 2.695 1 2.695 26.181 .004TRT 
Error .525 5.096 .103(c)    
Hypothesis .515 5 .103 2.863 .068TRT * PLATE 
Error .396 10.993 .036(d)    
Hypothesis 2.259 1 2.259 61.741 .000BLEED 
Error .424 11.592 .037(e)    
Hypothesis .874 1 .874 23.896 .000TRT * BLEED 
Error .424 11.592 .037(e)    
Hypothesis .349 10 .035 .355 .959TRT * BLEED 
* PLATE Error 4.126 42 .098(f)    
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a  .990 MS(PLATE) + .010 MS(Error) 
b   MS(TRT * PLATE) 
c  .990 MS(TRT * PLATE) + .010 MS(Error) 
d  .983 MS(TRT * BLEED * PLATE) + .017 MS(Error) 
e  .973 MS(TRT * BLEED * PLATE) + .027 MS(Error) 
f   MS(Error) 
 
C) Analysis of interaction of bleed and treatment 
BLEED * TRT 
 
Dependent Variable: ABS  
95% Confidence Interval 
BLEED TRT Mean Std. Error Lower Bound Upper Bound 
Peptide-
Injected 1.075 .074 .925 1.224 
Bleed 0 
Control .898 .083 .731 1.065 
Peptide-
Injected 1.684 .074 1.535 1.833 
Bleed 4 
Control 1.040 .083 .873 1.207 
 
 
 
II) Test to determine which calves have developed immunoreactive serum.  Refer to 
Chapter II Figure 9.  
 
A) 
Descriptives 
Note: N is the three absorbance repetitions of the Bleed 4, 1:50 dilution 
 N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval for 
Mean Minimum Maximum 
          Lower Bound Upper Bound     
Calf 412 3 1.1333 .52697 .30425 -.1757 2.4424 .55 1.57
Calf 435 3 2.0403 .61941 .35762 .5016 3.5790 1.36 2.58
Calf 426 3 1.4180 .51429 .29693 .1404 2.6956 .92 1.95
Calf 421 3 1.5217 .58095 .33541 .0785 2.9648 .86 1.97
Calf 420 3 1.9807 .51962 .30000 .6899 3.2715 1.40 2.40
Calf 417 3 2.0107 .44600 .25750 .9027 3.1186 1.55 2.44
Total 18 1.6841 .57551 .13565 1.3979 1.9703 .55 2.58
 
B) 
ANOVA 
 
Sum of 
Squares Df Mean Square F Sig. 
Between Groups 2.166 5 .433 1.501 .261 
Within Groups 3.465 12 .289    
Total 5.631 17     
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III) Test to determine which peptide(s) bind to the Bleed 4 sera from the peptide-injected 
calves the strongest:  Refer to Chapter II Table 7 and Figure 10. 
 
A) 
Between-Subjects Factors 
 
  Value Label N 
1.00 Bleed 0 195Bleed 
2.00 Bleed 4 195
1.00 Peptide 1 30
2.00 Peptide 2 30
3.00 Peptide 3 30
4.00 Peptide 4 30
5.00 Peptide 5 30
6.00 Peptide 6 30
7.00 Peptide 7 30
8.00 Peptide 8 30
9.00 Peptide 9 30
10.00 Peptide 10 30
11.00 Peptide 11 30
12.00 Peptide 12 30
Peptide 
13.00 Peptide 13 30
1.00 Plate 1 80
2.00 Plate 2 50
3.00 Plate 3 80
4.00 Plate 4 50
5.00 Plate 5 80
Plate 
6.00 Plate 6 50
 
Note: Note: N stands for the number of wells in the plate for three ELISA experiment 
repetitions corresponding to the categories of the value label. 
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B)  
Tests of Between-Subjects Effects 
 
Dependent Variable: Absorbance  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Hypothesis 120.882 1 120.882 115.007 .000Intercept 
Error 4.205 4.001 1.051(a)   
Hypothesis 21.338 11 1.940 25.653 .000PEPTIDE 
Error 1.664 22 .076(b)   
Hypothesis 4.210 4 1.052 13.918 .000PLATE 
Error 1.664 22 .076(b)   
Hypothesis 1.664 22 .076 .801 .699PEPTIDE * 
PLATE Error 2.454 26 .094(c)   
Hypothesis 27.134 1 27.134 287.486 .000BLEED 
Error 2.454 26 .094(c)   
Hypothesis 15.328 12 1.277 13.533 .000BLEED * 
PEPTIDE Error 2.454 26 .094(c)   
Hypothesis 2.454 26 .094 1.706 .019BLEED * 
PEPTIDE * 
PLATE 
Error 17.257 312 .055(d)   
a  .999 MS(PLATE) + .001 MS(PEPTIDE * PLATE) 
b   MS(PEPTIDE * PLATE) 
c   MS(BLEED * PEPTIDE * PLATE) 
d   MS(Error) 
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C) Analysis of interaction of bleed and peptide.  
Bleed * Peptide 
 
Dependent Variable: Absorbance  
95% Confidence Interval 
Bleed Peptide Mean Std. Error Lower Bound Upper Bound 
Peptide 1 .272(a) .061 .153 .392 
Peptide 2 .363(a) .061 .243 .482 
Peptide 3 .480(a) .061 .361 .600 
Peptide 4 .461(a) .061 .342 .581 
Peptide 5 .231(a) .061 .112 .351 
Peptide 6 .234(a) .061 .115 .354 
Peptide 7 .210(a) .061 .090 .329 
Peptide 8 .305(a) .061 .185 .424 
Peptide 9 .300(a) .061 .181 .420 
Peptide 10 .232(a) .061 .113 .352 
Peptide 11 .251(a) .061 .131 .370 
Peptide 12 .282(a) .061 .163 .402 
Bleed 0 
Peptide 13 .238(a) .061 .119 .358 
Peptide 1 .419(a) .061 .300 .539 
Peptide 2 1.549(a) .061 1.429 1.668 
Peptide 3 .937(a) .061 .817 1.056 
Peptide 4 .836(a) .061 .717 .956 
Peptide 5 .639(a) .061 .519 .758 
Peptide 6 .442(a) .061 .322 .561 
Peptide 7 .495(a) .061 .375 .614 
Peptide 8 1.095(a) .061 .975 1.214 
Peptide 9 1.746(a) .061 1.627 1.866 
Peptide 10 .417(a) .061 .298 .536 
Peptide 11 .929(a) .061 .809 1.048 
Peptide 12 .897(a) .061 .778 1.017 
Bleed 4 
Peptide 13 .318(a) .061 .198 .437 
a  Based on modified population marginal mean. 
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D) Analysis of interaction of peptide and calf. 
Between-Subjects Factors 
 
  Value Label N 
1.00 Peptide 1 15
2.00 Peptide 2 15
3.00 Peptide 3 15
4.00 Peptide 4 15
5.00 Peptide 5 15
6.00 Peptide 6 15
7.00 Peptide 7 15
8.00 Peptide 8 15
9.00 Peptide 9 15
10.00 Peptide 10 15
11.00 Peptide 11 15
12.00 Peptide 12 15
Peptide 
13.00 Peptide 13 15
1.00 Cow 417 39
2.00 Cow 420 39
3.00 Cow 421 39
4.00 Cow 426 39
Cow 
number 
5.00 Cow 435 39
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Cow number * Peptide 
 
Dependent Variable: Absorbance  
95% Confidence Interval 
Cow number Peptide Mean Std. Error Lower Bound Upper Bound 
Peptide 1 .314 .165 -.012 .641 
Peptide 2 1.147 .165 .820 1.474 
Peptide 3 .511 .165 .184 .837 
Peptide 4 .618 .165 .291 .945 
Peptide 5 .409 .165 .082 .735 
Peptide 6 .295 .165 -.032 .621 
Peptide 7 .281 .165 -.046 .607 
Peptide 8 .926 .165 .599 1.253 
Peptide 9 1.925 .165 1.599 2.252 
Peptide 10 .298 .165 -.029 .624 
Peptide 11 .644 .165 .317 .971 
Peptide 12 .761 .165 .434 1.087 
Cow 417 
Peptide 13 .255 .165 -.072 .582 
Peptide 1 .489 .165 .162 .816 
Peptide 2 2.314 .165 1.987 2.641 
Peptide 3 1.673 .165 1.346 1.999 
Peptide 4 1.225 .165 .898 1.552 
Peptide 5 .957 .165 .630 1.283 
Peptide 6 .426 .165 .099 .752 
Peptide 7 .883 .165 .556 1.209 
Peptide 8 .970 .165 .643 1.297 
Peptide 9 2.397 .165 2.070 2.723 
Peptide 10 .408 .165 .082 .735 
Peptide 11 1.322 .165 .996 1.649 
Peptide 12 1.076 .165 .749 1.403 
Cow 420 
Peptide 13 .336 .165 .009 .662 
Peptide 1 .505 .165 .179 .832 
Peptide 2 1.170 .165 .843 1.497 
Peptide 3 .883 .165 .556 1.209 
Peptide 4 .822 .165 .495 1.148 
Peptide 5 .664 .165 .337 .990 
Peptide 6 .528 .165 .201 .854 
Peptide 7 .469 .165 .142 .796 
Peptide 8 1.081 .165 .755 1.408 
Peptide 9 1.522 .165 1.195 1.849 
Peptide 10 .464 .165 .137 .790 
Peptide 11 .972 .165 .645 1.298 
Peptide 12 .950 .165 .624 1.277 
Cow 421 
Peptide 13 .360 .165 .034 .687 
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95% Confidence Interval  
 
Cow number 
 
 
Peptide 
 
 
Mean 
 
 
Std. Error Lower Bound Upper Bound 
Peptide 1 .375 .165 .048 .702 
Peptide 2 1.378 .165 1.052 1.705 
Peptide 3 .716 .165 .389 1.042 
Peptide 4 .593 .165 .266 .919 
Peptide 5 .453 .165 .127 .780 
Peptide 6 .460 .165 .134 .787 
Peptide 7 .381 .165 .054 .708 
Peptide 8 1.292 .165 .966 1.619 
Peptide 9 1.373 .165 1.046 1.700 
Peptide 10 .353 .165 .026 .680 
Peptide 11 .796 .165 .470 1.123 
Peptide 12 .660 .165 .333 .987 
Cow 426 
Peptide 13 .304 .165 -.022 .631 
Peptide 1 .412 .165 .086 .739 
Peptide 2 1.735 .165 1.408 2.061 
Peptide 3 .903 .165 .576 1.230 
Peptide 4 .925 .165 .598 1.251 
Peptide 5 .711 .165 .385 1.038 
Peptide 6 .500 .165 .173 .827 
Peptide 7 .461 .165 .134 .788 
Peptide 8 1.204 .165 .878 1.531 
Peptide 9 1.514 .165 1.187 1.841 
Peptide 10 .562 .165 .236 .889 
Peptide 11 .909 .165 .582 1.235 
Peptide 12 1.039 .165 .713 1.366 
Cow 435 
Peptide 13 .333 .165 .006 .660 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tests of Between-Subjects Effects 
 
Dependent Variable: Absorbance  
Source 
Type III Sum 
of Squares df Mean Square F Sig. 
Corrected Model 46.359(a) 64 .724 8.848 .000 
Intercept 132.552 1 132.552 1619.125 .000 
COW 5.174 4 1.293 15.800 .000 
PEPTIDE * COW 41.185 60 .686 8.385 .000 
Error 10.643 130 .082    
Total 189.553 195     
Corrected Total 57.001 194     
a  R Squared = .813 (Adjusted R Squared = .721) 
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APPENDIX II 
 
 
 Example of SPSS output for analyzing data from the tick challenge. 
 
I) Output for contingency table for the number of ticks molted collected from peptide-
injected calves versus control calves.  Refer to Chapter III Table 8. 
 
A)  
Treatment * Molt Crosstabulation 
 
    Molt Total 
        1.00     2.00   
Treatment     1.00 Count 128 22 150 
    Expected Count 124.5 25.5 150.0 
    % within Treatment 85.3% 14.7% 100.0% 
    % within Molt 51.4% 43.1% 50.0% 
      2.00 Count 121 29 150 
    Expected Count 124.5 25.5 150.0 
    % within Treatment 80.7% 19.3% 100.0% 
    % within Molt 48.6% 56.9% 50.0% 
Total Count 249 51 300 
  Expected Count 249.0 51.0 300.0 
  % within Treatment 83.0% 17.0% 100.0% 
  % within Molt 100.0% 100.0% 100.0% 
 
B) 
2x2 Chi-Square Tests 
 
  Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 1.158(b) 1 .282     
Continuity 
Correction(a) .850 1 .356     
Likelihood Ratio 1.161 1 .281     
Fisher's Exact Test    .357 .178 
N of Valid Cases 300       
a  Computed only for a 2x2 table 
b  0 cells (.0%) have expected count less than 5. The minimum expected count is 25.50. 
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II) Output for 2 sample T-tests for time to achieve 50% cumulative death and 100% 
cumulative death for the adults that molted from metanymphs that were detached from 
the peptide-injected calves and the control calves. 
 
A) 50% Death: Refer to Chapter III Table 10. 
Independent Samples Test 
 
    
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
    F Sig. T Df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
                  Lower Upper 
NUM Equal 
variances 
assumed 
.758 .409 -.175 8 .865 -.200 1.1402 -2.8292 2.4292
  Equal 
variances 
not 
assumed 
    -.175 7.777 .865 -.200 1.1402 -2.8424 2.4424
 
 
B)100% Death: Refer to Chapter III Table 11. 
Independent Samples Test 
 
    
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
    F Sig. T Df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
                  Lower Upper 
NUM Equal 
variances 
assumed 
1.258 .295 -1.131 8 .291 -.8000 .70711 -2.43059 .83059
  Equal 
variances 
not 
assumed 
    -1.131 7.082 .295 -.8000 .70711 -2.46812 .86812
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III) Output for the 2 sample T-tests for the average weight of fed females, the average 
weight of egg mass, and the average bloodmeal conversion of 30 ticks that dropped from 
2 peptide-injected calves and 4 control calves.  All the thirty measurements of the ticks 
that dropped from each peptide-injected calf were pooled for a total of 60 measurements 
to compare with the pooled measurements of the ticks that dropped from the control 
calves (120 measurements). 
 
A) Average Weight of Fed Females:  Refer to Chapter III Figure 17a. 
Group Statistics  
  TREATMENT N Mean Std. Deviation 
Std. Error 
Mean 
WEIGHT Control 120 .2539 .06809 .00622 
  Peptide 60 .2380 .04402 .00568 
 
Independent Samples Test  
 
    
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
    F Sig. T Df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
                  Lower Upper 
WEIGHT Equal 
variances 
assumed 
14.601 .000 1.644 178 .102 .0159 .00967 -.00319 .03499
  Equal 
variances 
not 
assumed 
   1.888 166.470 .061 .0159 .00842 -.00073 .03253
 
B) Average Weight of Egg Mass: Refer to Chapter III Figure 18a. 
Group Statistics 
 
  TREATMENT N Mean Std. Deviation 
Std. Error 
Mean 
EGGS Control 120 .0861 .05636 .00514 
  Peptide 60 .0850 .04053 .00523 
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Independent Samples Test 
 
    
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
    F Sig. t df 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
                  Lower Upper 
EGGS Equal 
variances 
assumed 
18.356 .000 .131 178 .896 .0011 .00817 -.01505 .01718
  Equal 
variances 
not 
assumed 
    .145 155.945 .885 .0011 .00734 -.01343 .01556
 
C) Average Bloodmeal Conversion: Refer to Chapter III Figure 19a. 
Group Statistics 
 
  TREATMENT N Mean Std. Deviation 
Std. Error 
Mean 
CONVERSI Control 120 .3323 .17905 .01635 
  Peptide 60 .3605 .16953 .02189 
 
Independent Samples Test 
 
    
Levene's Test 
for Equality of 
Variances t-test for Equality of Means 
    F Sig. t Df 
Sig. (2-
tailed) 
Mean 
Differen
ce 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
                  Lower Upper 
CONVERS
ION 
Equal 
variances 
assumed 
1.765 .186 -1.015 178 .312 -.0282 .02782 -.08313 .02667
  Equal 
variances 
not 
assumed 
   -1.033 124.039 .303 -.0282 .02732 -.08230 .02584
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APPENDIX III 
 
 This appendix describes how data was entered in the SPSS program. 
 
I) ELISA Data:  
A) Data analysis for bleeds 2-5 was entered analyzed as follows. 
 
For each dilution, a separate file was done.  The categories are as follows: 
Plate  Treatment  Bleed  Absorbance  Calf
 
The variables for each of the categories are numbers, for example for the Chapter II 
Figures 4-7 and Tables 3-6 this is how the data was entered: 
Plate: 1= plate 1, 2 = plate 2 and so on.  6 plates all together 
Treatment: 1= Control, 2 = Peptide-Injected 
Bleed: 1= Bleed 0, 2 = Bleed that we are testing 
Absorbance: enter the respective value of absorbance 
Calf: 1= Calf 407, 2= Calf 412, 3= Calf 438, 4= Calf 435 , 5= Calf 436, 6= Calf 426, 7= 
Calf 408, 8= Calf 421, 9= Calf 420, 10= Calf 427, 11= Calf 417 
  
To analyze the data in the menu choose Analyze Æ General Linear Model ÆUnivariate 
In the Univariate option, Dependent Variable = Absorbance, Random Factor = plate, and 
Fixed factors = treatment, bleed
Click on Model, choose Custom option.  Drag plate from the left over to the right where 
it says Model then move treatment to the right, choose plate and treatment at the same 
time and move them to the right (make sure interaction is chosen in the middle). Then 
bleed to the right.  Bleed and treatment to the right. Plate, bleed, treatment to the right. 
Click on Continue 
Back in Univariate click on Options and move Bleed*treatment over to the right where it 
says Display Means For. Click Continue 
Back in Univariate click OK. 
 
B) Data analysis for Bleed 4, 1:50 dilution antibody production, Chapter II Figure 8: 
Categories are as follows: 
Absorbance from Peptide Bleed 4     Calf
 
To analyze the data in the menu choose Analyze Æ Compare Means ÆOne-Way 
ANOVA 
In the One-Way ANOVA, Dependent List = Absorbance, Factor = Calf
Click on Options, choose Descriptives ÆContinue 
Click OK 
 
C) Data analysis for Bleed 0 vs Bleed 4 Peptides 1-13, Chapter II Figure 9 and Table 7: 
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Categories are as follows: 
Plate  Peptide Calf  Bleed  Absorbance
 
Plate: 1= plate 1, 2= plate 2 and so on. 6 plates all together 
Peptide: 1= Peptide 1, 2= Peptide 2, and so on.  13 Peptides all together 
Calf: 1= Calf 417, 2= Calf 420, 3= Calf 421, 4= Calf 426, 5= Calf 435 
Bleed: 1= Bleed 0, 2= Bleed 4 
Absorbance: what the absorbance was. 
 
To analyzes the data in the menu choose Analyze Æ General Linear Model ÆUnivariate 
In the Univariate option, Dependent Variable = Absorbance, Random Factor = plate, and 
Fixed factors = peptide,bleed
Click on Model, choose Custom option.  Move plate from the left over to the right where 
it says Model then move peptide to the right, choose plate and peptide at the same time 
and move them to the right (make sure interaction is chosen in the middle). Then bleed 
to the right.  Bleed and peptide to the right. Plate, bleed, peptide to the right. Click on 
Continue 
Back in Univariate click on Options and move Bleed*Peptide over to the right where it 
says Display Means For. Click Continue 
Back in Univariate click OK. 
 
 
II) Tick challenge Data: 
 
A) Data analyses for number of ticks molted from peptide-injected calves versus control 
calves.  A contingency table is performed. 
Categories are as follows: 
Trt  Molt  Count 
 
Treatment: 1= Control, 2 = Peptide-Injected 
Molt: 1 = Molted, 2 = Did Not Molt 
 
To analyze data in the menu choose Data Æ Weight cases, click on Weight cases by, 
Frequency variable = count, click OK 
Then Analyze ÆDescriptive Statistics Æ Crosstab
In Crosstab option, Row = Trt, Column = Molt.  Click on Percentage, click OK 
 
B) Data analysis for time to achieve 50% and 100% cumulative death. 
Categories are as follows: 
Trt  number 
 
Trt: 1= Control, 2 = Peptide-Injected 
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To analyze data in the menu choose Analyze Æ Compare means Æ Independent 
Samples T Test  
Test variable = number, Grouping variable is Trt.  Define Trt, Group 1=1, Group 2=2. 
Click OK 
 
C) Data analysis for average weight of fed females, average egg mass, average 
bloodmeal conversion of the peptide-injected calves versus the control calves: 
Categories are as follows: 
Trt      Weight/ Weight of Egg Mass/ Bloodmeal Conversion
 
Trt: 1= Control, 2 = Peptide-Injected 
 
To analyze data in the menu choose Analyze Æ Compare means Æ Independent 
Samples T Test  
Test variable = Weight/ etc., Grouping variable is Trt.  Define Trt, Group 1=1, Group 
2=2.  Click OK 
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APPENDIX IV 
 
I was bestowed the honor of being chosen as a fellow for the Hispanic 
Leadership Program in Agriculture and Natural Resources (HLPANR) for the 2003-
2004 and 2004-2005 academic years.  This great program focuses on research, 
leadership, professional development, and policy analysis.  My involvement in seminars, 
workshops, field trips, my leadership project, and presenting my research to the program 
has aided my goals of relating my research to the public and gaining leadership skills.   
The seminars and workshops have given me the opportunity to understand policy 
development, implementation, and analysis.  The speakers and the presentations on such 
topics of NAFTA and land-grant policies illustrated that policy development is a tool to 
improve the lives of disadvantaged people. 
The two field trips that I attended were to Uvalde, TX and Alice, TX.  This was 
an excellent opportunity to get to know the needs and experiences of the South Texas 
farmers and ranchers, first hand.  I was able to relate my research to the needs of the 
ranchers.  I observed how the farmers and ranchers apply their knowledge of 
entomology for their use of agriculture.     
My leadership project was to expose Hispanics to the study of entomology and 
the opportunities that entomology has to offer by translating recruiting materials into 
Spanish and attending college recruiting programs.  The recruiting programs that I 
attended were the February 26, 2005 Aggieland Saturday at Texas A&M and the April 9, 
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2005 Houston Hispanic Forum Career and Education Day.  From this experience, I have 
learned that recruiting for Hispanic college students is a tough job because some think 
that college is not a possibility for them but at least the seed of higher education has been 
planted in their minds and they were able to get information that they might not 
otherwise have obtained. 
 I have presented my research to all of the fellows and administrators of the 
program.  That was an invaluable experience since most of the fellows studied such 
diverse subjects such as English, Poultry science, and Agronomy.  I developed the skills 
to communicate and disseminate information in a manner understandable to diverse 
audiences.  I have been fortunate to have been part of this program. 
 
List of activities that I attended: 
 
August 28-29, 2003  HLPANR Orientation Program for AY 2003-2004 at Woodfield 
Suites, UTSA in San Antonio 
October 18, 2003 Policy Analysis Workshop at Texas A&M in College Station 
November 7, 2003  USFS Policy Workshop at San Antonio 
 
March 5-6, 2004 HLPANR Uvalde Field trip in Uvalde, Texas 
April 10-11, 2004 Fellows Research Presentations at UTSA, San Antonio 
July 23-24, 2004 HLPANR meeting            
August 27-28, 2004  HLPANR Orientation Program for AY 2004-2005 at Reed Arena, 
Texas A&M in College Station 
October 22-23, 2004  Policy Workshop at Woodfield Suites, UTSA in San Antonio 
November 12, 2004 HLPANR Meeting at Rudder Tower, Texas A&M in College 
Station 
 
February 11-12, 2005  HLPANR Alice Field trip in Alice, Texas 
April 15-16, 2005  Policy Workshop and Research Presentations at Rudder Tower, 
Texas A&M in College Station 
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